Cirtec Medical Appoints New CEO Shar Matin
Cirtec Medical, a prominent partner in the production of complex minimally invasive medical devices, has announced the appointment of Shar Matin as their new Chief Executive Officer. This pivotal change comes as the company gears up to amplify its growth and innovation in the medical technology sector.
Shar Matin's Extensive Experience in Medical Technology
Bringing over 25 years of extensive leadership experience in the medical device industry, Shar Matin is set to bring a wealth of knowledge to Cirtec Medical. He has a notable history of successfully driving transformations within various companies. His most recent position was as CEO of Cordis, where he played a crucial role in elevating the company to become one of the largest cardiovascular entities globally. This included spearheading significant acquisitions, such as that of MedAlliance, known for advanced drug-eluting balloon technology.
Proven Track Record of Innovation
Before his tenure at Cordis, Matin held executive roles at several prestigious organizations, including ViewRay Technologies, Spectranetics, Boston Scientific, and Guidant. His career trajectory reflects a consistent commitment to innovation, strategic expansion, and enhancing customer partnerships. His journey began as a process and manufacturing engineer, which laid the foundation for his accomplishments in the field.
Comments from Cirtec Board Member
Rich Relyea, a member of the Cirtec Board and Partner at 3i Private Equity, expressed enthusiasm over Matin's appointment, stating, "Shar is an experienced leader with a demonstrated ability to accelerate growth, strengthen customer partnerships, and drive innovation. On behalf of the Board, we are excited to welcome him to Cirtec and are confident he will build on the company’s strong foundation."
Matin's Vision for Cirtec Medical
Upon his appointment, Matin has expressed gratitude and enthusiasm for leading Cirtec into its next growth phase. He emphasized the company’s strong momentum and shared his commitment to enhancing patient care through innovative medical technologies. His vision aligns closely with Cirtec’s mission to transform cutting-edge technology into life-changing medical devices.
Transition of Leadership
The transition of leadership has also been marked by the Board’s appreciation for former CEO Brian Highley. Over the past decade, Highley has been instrumental in shaping Cirtec into a leading Contract Development and Manufacturing Organization (CDMO), steering the company through significant growth and solidifying its position in the industry. His contributions have established Cirtec as a trusted partner for innovative medical technology companies.
Interim Leadership Acknowledgment
The Board has also conveyed gratitude to Ed Philbin, who served as Interim CEO in the months leading up to Matin’s appointment. His leadership was vital in maintaining company momentum during the transition, ensuring a robust handover of responsibilities to the new CEO.
About Cirtec Medical
Cirtec Medical stands at the forefront of design, development, and manufacturing of complex Class II and III medical devices. Specializing in active implant systems, their expertise extends across various therapies, including cardiology, neurology, and orthopedics. With a commitment to quality and performance in every stage of the product lifecycle, Cirtec Medical aims to expedite market entry, minimize risks, and enhance revenue generation for its partners.
Contact Information
For media inquiries, please reach out to:
Abby Kupka
Sr. Manager, Marketing
Cirtec Medical
(763) 235-8835
Frequently Asked Questions
Who is the new CEO of Cirtec Medical?
The new CEO of Cirtec Medical is Shar Matin, who brings extensive experience in the medical technology field.
What is Shar Matin's background?
Shar Matin has over 25 years in medical technology, having served as CEO at Cordis and held positions at companies like ViewRay and Boston Scientific.
What is Cirtec Medical known for?
Cirtec Medical specializes in the design and manufacturing of complex medical devices, particularly active implant systems and minimally invasive devices.
Why did Cirtec Medical change leadership?
The leadership transition aims to accelerate growth and innovation in line with the company’s mission to advance patient care through technology.
How has Cirtec Medical performed under Brian Highley?
Under Brian Highley’s leadership, Cirtec transformed into a leading CDMO, achieving remarkable growth and establishing strong partnerships in the industry.
